Global Market Access, Agilent
Biography
Dana Dilbeck has over 20 years of Executive Healthcare experience primarily in the Oncology sector. Most recently in the life science industry focused on molecular diagnostic testing to advance cancer care. She is currently the
Senior Director Market Access, Reimbursement and Pricing for Agilent. Previously, Director of Payer Relationships and Reimbursement for Pacific Edge Diagnostics. In addition, she served as the Vice President for a molecular diagnostic company, that provides a large next generation sequencing (NGS) panel for oncology care. Dilbeck worked for McKesson Specialty Health-US Oncology for over 15 years focused on Payer Strategy and Public Policy for the National Network of over 1000 + physicians. Managing contracting and strategies for comprehensive Oncology services. Additional experience includes MD Anderson Cancer Center.
Dilbeck is an expert in physician reimbursement and managed care pricing strategies to address high-cost cancer care services. Dilbeck has a bachelor’s degree in Economics and Management from Rice University.
Session Abstract – PMWC 2023 Silicon Valley
Track 4 - January 26 9.00 A.M.-4.30 P.M.
Track Chair: Cindy Perettie, Roche
- PMWC 2023 Award Ceremony
- Luis Alberto Diaz Jr., MSK
- Razelle Kurzrock, Medical College of Wisconsin - Non-invasive Liquid Biopsy Techniques (PANEL)
Chair: Razelle Kurzrock, Medical College of Wisconsin
- Apostolia Tsimberidou, MD Anderson
- Mandana Kamgar, MD Medical College of Wisconsin
- Mina Nikanjam, UCSD
- Ash Alizadeh, Stanford University - Liquid Biopsy Challenges and Limitations (PANEL)
Chair: Victor Lin, Mary Bird Perkins
- Luis Alberto Diaz Jr., MSK
- Maximilian Diehn, Stanford
- Dana Dilbeck, Agilent
- Emma Shtivelman, Cancer Commons - Liquid Biopsy in Clinical Trials: Learnings and COVID Experience (PANEL)
Chair: Cindy Perettie, Roche Diagnostics
- Eric Peters, Genenetch
- Andrew Mckenzie, Sarah Cannon
- Yang Pan, Gilead
- Alan Sandler, Mirati Therapeutics - Multi-Cancer Early Detection Through Multi-Biomarker Class Liquid Biopsy Testing
Chair: Tom Beer, Exact Sceinces
- Liquid Biopsy for Early Cancer Detection (PANEL)
Chair: Priti Hegde, Foundation Medicine
- Daniel Kim, UCSC
- Mike Nolan, Freenome
- Jeffrey Venstrom, Grail Bio
- Kathryn Phillips, UCSF
- Lon Castle, eviCore healthcare
- Tom Beer, Exact Sciences - Liquid Biopsy for Minimal Residual Disease (PANEL)
Chair: Minetta Liu, Natera
- Peter Bach, Delfi diagnostics
- Laura Vantveer, UCSF
- Susan Bobulsky, Adaptive
- Joshua Cohen, Johns Hopkins
- PMWC Showcase
- Harmeet Dhani, Biological Dynamics
- Varsha Rao, Claret Bio - PMWC NCI Showcase
- Xianghong Jasmine Zhou, EarlyDiagnostics
